GSK vs XEL · P/E 13, $103.31B cap vs P/E 20, $39.33B cap
GlaxoSmithKline PLC ADR (GSK) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
GSK does not have a complete income-statement cache yet.
XEL does not have a complete income-statement cache yet.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the GSK and XEL stock pages for the full models.
Not investment advice.